Business Context and Reporting Period
This Form 8-K is a current report filed by Marathon Patent Group, Inc. (noting the metadata reference to MARA Holdings, Inc. appears to be a discrepancy as the filing explicitly names Marathon Patent Group, Inc.) on September 29, 2017. The report details the final closing of a private placement offering, the transfer of assets to the CEO, executive employment changes, board compensation adjustments, and the results of a special shareholder meeting.
Key Financial Metrics and Capital Structure
- Capital Raised: The Company completed the sale of $5,500,000 in aggregate principal amount of 5% secured convertible promissory notes and associated warrants.
- Offering Details: The final tranche of $1,876,300 was sold on September 28, 2017, following a prior issuance of $3,623,700.
- Dilution Potential: The total offering is convertible and exercisable for up to 82,500,000 shares of common stock (54,355,500 from the initial tranche and 28,144,500 from the final tranche).
- Warrant Terms: Warrants have an exercise price of $0.30 per share and a five-year term.
- Outstanding Shares: As of the record date for the special meeting, 29,492,066 shares of common and preferred stock (on an as-converted basis) were issued and outstanding.
- Liquidity and Debt: The filing does not provide specific cash flow, liquidity, or total debt figures beyond the new $5.5 million note issuance.
Material Changes and Corporate Actions
- Asset Disposition: The Company transferred 100% of its beneficial ownership of 3D Nanocolor Corp. shares to CEO Doug Croxall pursuant to a Retention Agreement.
- Executive Departure: CEO Doug Croxall's last day of employment was deferred from October 1, 2017, to October 31, 2017. He is permitted to pursue outside business activities related to 3D Nanocolor Corp.
- Board Compensation: The Board approved the issuance of restricted common stock to four independent directors (totaling 800,000 shares) and established cash compensation of $1,000 per month plus committee fees.
- Shareholder Approvals: Shareholders approved the restructuring agreement with DBD Credit Funding LLC, the issuance of the $5.5 million convertible notes, the 2017 Equity Incentive Plan (reserving 10,000,000 shares), and the exchange of warrants for 2,394,000 shares of common stock.
Guidance, Risks, and Contingencies
The filing does not contain forward-looking financial guidance or specific management commentary on future performance. Key risks and contingencies identified include:
- Dilution Risk: The issuance of up to 82,500,000 shares upon conversion of the new notes represents a significant potential increase in the share count relative to the 29.5 million shares outstanding.
- Related Party Transactions: The transfer of 3D Nanocolor Corp. assets to the CEO and the approval of his outside business activities present potential conflict of interest considerations.
- Restructuring Obligations: The Company is bound by a Revenue Sharing and Securities Purchase Agreement with DBD Credit Funding LLC, involving the contribution of intellectual property to a special purpose entity.
Investor Verification Checklist
- Verify the exact conversion price and anti-dilution provisions of the $5.5 million convertible notes in the exhibits (4.1 and 10.1).
- Confirm the current valuation and strategic relevance of the 3D Nanocolor Corp. assets transferred to the CEO.
- Review the terms of the Revenue Sharing Agreement with DBD Credit Funding LLC to understand ongoing royalty or payment obligations.
- Assess the impact of the 10,000,000 share reservation under the new Equity Incentive Plan on future dilution.
- Clarify the discrepancy between the metadata company name (MARA Holdings, Inc.) and the filing registrant (Marathon Patent Group, Inc.).